Review




Structured Review

Accelrys discovery studio 3.0 software package
Discovery Studio 3.0 Software Package, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/discovery studio 3.0 software package/product/Accelrys
Average 90 stars, based on 1 article reviews
discovery studio 3.0 software package - by Bioz Stars, 2026-06
90/100 stars

Images



Similar Products

90
Accelrys discovery studio 3.0 software package
Discovery Studio 3.0 Software Package, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/discovery studio 3.0 software package/product/Accelrys
Average 90 stars, based on 1 article reviews
discovery studio 3.0 software package - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Accelrys discovery studio 3.0 software package pharmacophore generation
2D Chemical structures of 18 training set used to obtain HypoGen <t>pharmacophore</t> hypotheses.
Discovery Studio 3.0 Software Package Pharmacophore Generation, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/discovery studio 3.0 software package pharmacophore generation/product/Accelrys
Average 90 stars, based on 1 article reviews
discovery studio 3.0 software package pharmacophore generation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


2D Chemical structures of 18 training set used to obtain HypoGen pharmacophore hypotheses.

Journal: PLoS ONE

Article Title: Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

doi: 10.1371/journal.pone.0059315

Figure Lengend Snippet: 2D Chemical structures of 18 training set used to obtain HypoGen pharmacophore hypotheses.

Article Snippet: The following program were used in the manuscript: Discovery Studio 3.0 software package for pharmacophore model generation (DS, Accelrys Inc., San Diego, USA); Gold 5.0 program for molecular docking (CCDC, UK); Derek 2.0.3 for the toxicities prediction (Lhasa Inc., UK); MarvinSketch 5.10.0 for the physicochemical properties prediction (Chemaxon Ltd., USA).

Techniques:

2D chemical structures of 30 test set molecules for the pharmacophore model validation.

Journal: PLoS ONE

Article Title: Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

doi: 10.1371/journal.pone.0059315

Figure Lengend Snippet: 2D chemical structures of 30 test set molecules for the pharmacophore model validation.

Article Snippet: The following program were used in the manuscript: Discovery Studio 3.0 software package for pharmacophore model generation (DS, Accelrys Inc., San Diego, USA); Gold 5.0 program for molecular docking (CCDC, UK); Derek 2.0.3 for the toxicities prediction (Lhasa Inc., UK); MarvinSketch 5.10.0 for the physicochemical properties prediction (Chemaxon Ltd., USA).

Techniques:

Results of  pharmacophore  hypotheses generated by HypoGen.

Journal: PLoS ONE

Article Title: Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

doi: 10.1371/journal.pone.0059315

Figure Lengend Snippet: Results of pharmacophore hypotheses generated by HypoGen.

Article Snippet: The following program were used in the manuscript: Discovery Studio 3.0 software package for pharmacophore model generation (DS, Accelrys Inc., San Diego, USA); Gold 5.0 program for molecular docking (CCDC, UK); Derek 2.0.3 for the toxicities prediction (Lhasa Inc., UK); MarvinSketch 5.10.0 for the physicochemical properties prediction (Chemaxon Ltd., USA).

Techniques: Generated

A and C, S1 and S13 binding to the active site of Hsp90, respectively. B and D, S1 and S13 mapped onto the pharmacophore model Hypo1, respectively. S1, S13 and the key residues were shown as stick. H-bond was colored in red. Hypothesis features are color-coded as follows: hydrophobic aromatic, light blue; hydrogen bond donor, violet; hydrogen bond acceptor, green.

Journal: PLoS ONE

Article Title: Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

doi: 10.1371/journal.pone.0059315

Figure Lengend Snippet: A and C, S1 and S13 binding to the active site of Hsp90, respectively. B and D, S1 and S13 mapped onto the pharmacophore model Hypo1, respectively. S1, S13 and the key residues were shown as stick. H-bond was colored in red. Hypothesis features are color-coded as follows: hydrophobic aromatic, light blue; hydrogen bond donor, violet; hydrogen bond acceptor, green.

Article Snippet: The following program were used in the manuscript: Discovery Studio 3.0 software package for pharmacophore model generation (DS, Accelrys Inc., San Diego, USA); Gold 5.0 program for molecular docking (CCDC, UK); Derek 2.0.3 for the toxicities prediction (Lhasa Inc., UK); MarvinSketch 5.10.0 for the physicochemical properties prediction (Chemaxon Ltd., USA).

Techniques: Binding Assay